A study on expression mechanisms and functions of a novel adhesion molecule, trophinin
新型粘附分子Trothinin的表达机制和功能研究
基本信息
- 批准号:10470348
- 负责人:
- 金额:$ 6.53万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1. Biological significance of β1, 4-galactosyltransferase in gynecological cancerWe have established a system that selectively measures the activity ofβ-1, 3-galactosyltransferase (β1, 3GT) andβ-1, 4-galactosyltransferase (β1, 4GT), and we measured the activity of both. We also assessed the expression of β1, 4GTmRNA by the Northern blot analysis. The results revealed higherβ1, 3GT activity thanβ1, 4GT activity in uterineendometrial cancer analysis, and the level of expression ofβ1, 4GTmRNA was lower than in uterine cervix cancer and ovarian cancer. We also transfected humanβ1, 4GTcDNA into a uterine endometrial cancer and ovarian cancer derived cell lines, and established a high-expressionβ1, 4GT line and a low-expression line, and investigated the cellular properties of each. The results showed that the cell proliferation capacity and ability to adhere to the extracellular matrix by the high-expressionβ1,4GT line were greater than in the control, and that the cell proliferation capaci … More ty and the ability of adhere to the extracellular matrix by the low expressionβ1, 4GT line were less than in the control. These findings suggested thatβ1, 4GT may be involved in the properties of uterine endometrial cancer and ovarian cancer cells.2. Expression of the AKT2 gene in gynecological cancerThe product of the recently cloned AKT2 gene has been found to be a cell proliferation signal transmitter, and it has been suggested that the presence or absence of abnormal amplification of the AKT2 gene in pancreatic cancer is associated with disease progression and outcome. We therefore analyzed the expression dynamics of the AKT2 were used as a probe to assess the frequency of AKT2 amplification in ovarian cancer patients by the slot-blot method, with the non-cancerous portion of the same specimen being used as a control. The results revealed abnormal amplification of the AKT2 gene in one of six uterine endometrial cancer cell lines in an analysis using cultured cells, whereas no abnormal amplification of the AKT2 gene was detected among the 25 ovarian cancer patients. Less
1. β1, 4-半乳糖基转移酶在妇科癌症中的生物学意义我们建立了选择性测量β-1, 3-半乳糖基转移酶(β1, 3GT)和β-1, 4-半乳糖基转移酶(β1, 4GT)活性的系统,并测量了两者的活性。我们还通过 Northern blot 分析评估了 β1、4GTmRNA 的表达。结果显示,子宫内膜癌中β1、3GT活性高于β1、4GT活性,且β1、4GTmRNA表达水平低于子宫颈癌和卵巢癌。我们还将人β1、4GTcDNA转染至子宫内膜癌和卵巢癌来源的细胞系中,建立了高表达β1、4GT细胞系和低表达细胞系,并研究了各自的细胞特性。结果显示,高表达β1,4GT细胞系的细胞增殖能力和细胞外基质粘附能力均大于对照,而低表达β1,4GT细胞系的细胞增殖能力和细胞外基质粘附能力低于对照。这些结果提示β1、4GT可能参与子宫内膜癌和卵巢癌细胞的特性。 2. AKT2基因在妇科癌症中的表达最近克隆的AKT2基因产物被发现是一种细胞增殖信号递质,有人提出胰腺癌中AKT2基因异常扩增的存在或不存在与疾病进展和结果相关。因此,我们分析了 AKT2 的表达动态,将其用作探针,通过槽印迹法评估卵巢癌患者中 AKT2 扩增的频率,并使用同一样本的非癌部分作为对照。结果显示,在使用培养细胞进行的分析中,六种子宫内膜癌细胞系之一的 AKT2 基因异常扩增,而在 25 名卵巢癌患者中未检测到 AKT2 基因异常扩增。较少的
项目成果
期刊论文数量(20)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Shin-ichi Komiyama,Daisuke Aoki,Shiro Nozawa,et al.3: "Pognosis of japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis clinicopathologic evaluation"Gynecologic Oncology. 72. 345-346 (1999)
Shin-ichi Komiyama,Daisuke Aoki,Shiro Nozawa,等3:“与盆腔子宫内膜异位症相关的日本卵巢透明细胞癌患者的预后评估”妇科肿瘤学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takuya Irie,Kaneyuki Kubushiro,Shiro Nozawa,et al.3: "Inhibition of attachment and chemotactic invasion of uterine endometrial cancer cell by a new vinca alkaloid,conophylline"Anticancer Reseatch. 19. 3061-3066 (1999)
Takuya Irie,Kaneyuki Kubushiro,Shiro Nozawa,等3:“一种新的长春花生物碱,conophylline抑制子宫内膜癌细胞的附着和趋化侵袭”抗癌研究。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kaneyuki Kubushiro, et al. 6: "Change of β-1, 4-Galactosyltransferase with the Development of endometrial cancer"Gynecol. Obstet. Invest.. 48. 211-214 (1998)
Kaneyuki Kubushiro 等人 6:“β-1, 4-半乳糖基转移酶与子宫内膜癌发生的关系”Gynecol Invest.. 48. 211-214 (1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Daisuke Aoki, et al. 6: "Two soluble forms of β1,4-galactosyltransferase released from ovarian cancer cells from COS-1 cells transfected with its cDNA"Acta Histochem. Cytochem.. 32(3). 209-214 (1999)
Daisuke Aoki 等人 6:“用其 cDNA 转染的 COS-1 细胞释放出两种可溶形式的 β1,4-半乳糖基转移酶”Acta Histochem. 32(3) (1999)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Michiko N.Fukuda and Shiro Nozawa: "Trophinin,tastin and bystin:A complex mediating uniqe attachment between trophoblastic and endometrial epithelial cells at their respective apical cell membranes"Seminars in Reproductive Endcrinology. 17.3. 229-234 (199
Michiko N.Fukuda 和 Shiro Nozawa:“Trophinin、tastin 和 bystin:一种复合物介导滋养层细胞和子宫内膜上皮细胞在各自的顶端细胞膜上的独特附着”生殖内分泌学研讨会。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NOZAWA Shiro其他文献
NOZAWA Shiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NOZAWA Shiro', 18)}}的其他基金
Establishment of a new human monoclonal antibody using mice that produce complete human antibodies and applications to cancer treatment
利用产生完整人源抗体的小鼠建立新型人源单克隆抗体及其在癌症治疗中的应用
- 批准号:
14207065 - 财政年份:2002
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Development of human monoclonal antibodies using TC(Trans Chromosomic) mice
使用TC(Trans Chromosomic)小鼠开发人单克隆抗体
- 批准号:
12470347 - 财政年份:2000
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of New Diagnostic Methods to Recognize the Fucosylated Carbohydrate Chains Expressed by Endometrial Cancer Cells and Clinical Applications
开发新的诊断方法来识别子宫内膜癌细胞表达的岩藻糖基化碳水化合物链及其临床应用
- 批准号:
12557140 - 财政年份:2000
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A stuby on expression mechanisms and functions of a novel adhesion molecule, trophinin
新型粘附分子 Trophynin 的表达机制和功能研究
- 批准号:
08457443 - 财政年份:1996
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The development of a new diagnostic method for uterine endometrial cancer, using monoclonal antibody for glicolipids, and its application for mass screening
使用糖脂单克隆抗体开发子宫内膜癌新诊断方法及其在大规模筛查中的应用
- 批准号:
06557088 - 财政年份:1994
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
The expression mechanism of glycosyltransferases in adenocarcimoma cells -a study using endometrial and ovarian adenocarcimomas-
腺癌细胞中糖基转移酶的表达机制-以子宫内膜和卵巢腺癌为对象的研究-
- 批准号:
06454479 - 财政年份:1994
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Glycolipids analysis in female genital organs originated from Muller's duct : relationship to the extracellular matrix
来自米勒管的女性生殖器官中的糖脂分析:与细胞外基质的关系
- 批准号:
04454424 - 财政年份:1992
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Analysis of glycoconjugates of the female genital tract : -with special reference to their changed dependent on the hormonal environment and malignant transformation-
女性生殖道糖缀合物的分析:-特别参考它们的变化依赖于激素环境和恶性转化-
- 批准号:
02454389 - 财政年份:1990
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Analysis of Glycolipids in Human Endometrium - using mouse and human monoclonal antibodies -
人子宫内膜中的糖脂分析 - 使用小鼠和人单克隆抗体 -
- 批准号:
62480351 - 财政年份:1987
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
A novel mechanism of menopause-induced endometrial cancer that develops through functional loss of the helicase family
更年期诱发子宫内膜癌的新机制是通过解旋酶家族功能丧失而发生的
- 批准号:
24K19688 - 财政年份:2024
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mechanisms of tamoxifen-associated endometrial cancer risk
他莫昔芬相关子宫内膜癌风险的机制
- 批准号:
10650054 - 财政年份:2023
- 资助金额:
$ 6.53万 - 项目类别:
Project 1: Targeting HSPA Proteins in Advanced and Recurrent Endometrial Cancer Therapy
项目 1:针对晚期和复发性子宫内膜癌治疗中的 HSPA 蛋白
- 批准号:
10711636 - 财政年份:2023
- 资助金额:
$ 6.53万 - 项目类别:
Detection of imaging features related to node metastasis in uterine endometrial cancer
子宫内膜癌淋巴结转移相关影像学特征的检测
- 批准号:
23K07209 - 财政年份:2023
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of new endocrine therapy based on genomic classification for endometrial cancer
基于子宫内膜癌基因组分类开发新内分泌疗法
- 批准号:
23K15818 - 财政年份:2023
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Claims-based measures of care coordination and long-term health among older women with endometrial cancer
患有子宫内膜癌的老年妇女的基于索赔的护理协调和长期健康措施
- 批准号:
10579456 - 财政年份:2023
- 资助金额:
$ 6.53万 - 项目类别:
Elucidation of molecular mechanisms involved in the diversity and plasticity of endometrial cancer stem cells and development of novel multifaceted therapies
阐明子宫内膜癌干细胞多样性和可塑性的分子机制并开发新型多方面疗法
- 批准号:
23H03044 - 财政年份:2023
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Endometrial Cancer Survival and Survivorship among Latinas in California: A Mixed Methods Study
加利福尼亚州子宫内膜癌生存率和拉丁裔生存率:一项混合方法研究
- 批准号:
10461655 - 财政年份:2023
- 资助金额:
$ 6.53万 - 项目类别:
Establishment of predictive factor of oncologic / pregnancy outcome on fertility sparing treatment for young patients with endometrial cancer
年轻子宫内膜癌患者保留生育治疗的肿瘤/妊娠结局预测因素的建立
- 批准号:
23K08808 - 财政年份:2023
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Combination Therapies Targeting Insulin Signaling in Endometrial Cancer
子宫内膜癌中针对胰岛素信号传导的联合疗法
- 批准号:
10637167 - 财政年份:2023
- 资助金额:
$ 6.53万 - 项目类别: